Home › Funds › Arrowstreet Capital › VRTX
Arrowstreet Capital position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)738.38K sh
Reported value held$366.77M
Portfolio Weight0.16%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 24.25K | $5.33M | New |
| Q2 2022 | 9.79K | $2.76M | New |
| Q3 2022 | 5.09K | $1.47M | Reduce |
| Q4 2022 | 5.23K | $1.51K | Add |
| Q4 2024 | 9.27K | $3.73M | New |
| Q2 2025 | 61.47K | $27.37M | New |
| Q3 2025 | 381.19K | $149.29M | Add |
| Q4 2025 | 593.95K | $269.27M | Add |
| Q1 2026 | 638.95K | $285.32M | Add |
| Q2 2026 | 738.38K | $366.77M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026